200 related articles for article (PubMed ID: 22684556)
21. Evaluation of the correlation of vasculogenic mimicry, ALDH1, KAI1 and microvessel density in the prediction of metastasis and prognosis in colorectal carcinoma.
Zhu B; Zhou L; Yu L; Wu S; Song W; Gong X; Wang D
BMC Surg; 2017 Apr; 17(1):47. PubMed ID: 28431527
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.
Wang Y; Yang R; Wang X; Ci H; Zhou L; Zhu B; Wu S; Wang D
Medicine (Baltimore); 2018 Dec; 97(52):e13817. PubMed ID: 30593175
[TBL] [Abstract][Full Text] [Related]
23. Thrombin is a therapeutic target for non-small-cell lung cancer to inhibit vasculogenic mimicry formation.
Zhao B; Wu M; Hu Z; Ma Y; Qi W; Zhang Y; Li Y; Yu M; Wang H; Mo W
Signal Transduct Target Ther; 2020 Jul; 5(1):117. PubMed ID: 32647187
[TBL] [Abstract][Full Text] [Related]
24. N-myc downstream-regulated gene 1 can promote vasculogenic mimicry and angiogenesis in urothelial carcinoma.
Louis EK; Abdelkawi IF; Refaiy A; Ahmed AM
Virchows Arch; 2024 May; 484(5):827-836. PubMed ID: 38561462
[TBL] [Abstract][Full Text] [Related]
25. Predictive value of intratumoral microvascular density in patients with advanced non-small cell lung cancer receiving chemotherapy plus bevacizumab.
Zhao YY; Xue C; Jiang W; Zhao HY; Huang Y; Feenstra K; Resau JH; Qian CN; Zhang L
J Thorac Oncol; 2012 Jan; 7(1):71-5. PubMed ID: 22011670
[TBL] [Abstract][Full Text] [Related]
26. Maspin gene expression is a significant prognostic factor in resected non-small cell lung cancer (NSCLC). Maspin in NSCLC.
Katakura H; Takenaka K; Nakagawa M; Sonobe M; Adachi M; Ito S; Wada H; Tanaka F
Lung Cancer; 2006 Mar; 51(3):323-8. PubMed ID: 16406136
[TBL] [Abstract][Full Text] [Related]
27. Expression of Elf-1 and survivin in non-small cell lung cancer and their relationship to intratumoral microvessel density.
Yang DX; Li NE; Ma Y; Han YC; Shi Y
Chin J Cancer; 2010 Apr; 29(4):396-402. PubMed ID: 20346215
[TBL] [Abstract][Full Text] [Related]
28. Relationship between the expression of ARHGAP25 and RhoA in non-small cell lung cancer and vasculogenic mimicry.
Shi F; Wu J; Jia Q; Li K; Li W; Shi Y; Wang Y; Wu S
BMC Pulm Med; 2022 Oct; 22(1):377. PubMed ID: 36207695
[TBL] [Abstract][Full Text] [Related]
29. [Vasculogenic mimicry in laryngeal squamous cell carcinoma and its clinicopathological significance].
Wu S; Yu L; Zhou L; Cheng Z; Wang D
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Aug; 31(4):865-9. PubMed ID: 25464804
[TBL] [Abstract][Full Text] [Related]
30. Maspin expression and subcellular localization in invasive ductal carcinoma of the breast: Prognostic significance and relation to microvessel density.
Helal DS; El-Guindy DM
J Egypt Natl Canc Inst; 2017 Dec; 29(4):177-183. PubMed ID: 29126758
[TBL] [Abstract][Full Text] [Related]
31. Microvessel density and expression of thrombospondin-1 in non-small cell lung cancer and their correlation with clinicopathological features.
Chen ZJ; Le HB; Zhang YK; Qian LY; Li WD
J Int Med Res; 2009; 37(2):551-6. PubMed ID: 19383251
[TBL] [Abstract][Full Text] [Related]
32. Number of circulating endothelial progenitor cells and intratumoral microvessel density in non-small cell lung cancer patients: differences in angiogenic status between adenocarcinoma histologic subtypes.
Maeda R; Ishii G; Ito M; Hishida T; Yoshida J; Nishimura M; Haga H; Nagai K; Ochiai A
J Thorac Oncol; 2012 Mar; 7(3):503-11. PubMed ID: 22198428
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of Nuclear Heat Shock Factor 1 Contributes to Tumor Angiogenesis and Poor Survival in Patients With Non-Small Cell Lung Cancer.
Cui J; Tian H; Chen G
Ann Thorac Surg; 2015 Aug; 100(2):465-72. PubMed ID: 26095102
[TBL] [Abstract][Full Text] [Related]
34. The Relationship Between UBE2C and AGGF1 Overexpression and Tumor Angiogenesis in Non-Small Cell Lung Cancer.
Wang Y; Shi F; Tao R; Wu J; Gu J; Yang R; Wu S
Cancer Manag Res; 2021; 13():5919-5930. PubMed ID: 34354374
[TBL] [Abstract][Full Text] [Related]
35. The natural tumor suppressor protein maspin and potential application in non small cell lung cancer.
Lonardo F; Li X; Kaplun A; Soubani A; Sethi S; Gadgeel S; Sheng S
Curr Pharm Des; 2010 Jun; 16(16):1877-81. PubMed ID: 20337574
[TBL] [Abstract][Full Text] [Related]
36. Nuclear and cytoplasmic Maspin expression in primary non-small cell lung cancer.
Woenckhaus M; Bubendorf L; Dalquen P; Foerster J; Blaszyk H; Mirlacher M; Soler M; Dietmaier W; Sauter G; Hartmann A; Wild PJ
J Clin Pathol; 2007 May; 60(5):483-6. PubMed ID: 16698957
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor expression and neovascularization in non--small cell lung carcinoma.
Ozbudak IH; Ozbilim G; Kucukosmanoglu I; Dertsiz L; Demircan A
Int J Surg Pathol; 2009 Oct; 17(5):390-5. PubMed ID: 18849317
[TBL] [Abstract][Full Text] [Related]
38. Expression of hypoxia-inducible factor prolyl hydroxylase 3 HIFPH3 in human non-small cell lung cancer (NSCLC) and its correlation with prognosis.
Chu X; Zhu CC; Liu H; Wang JC
Asian Pac J Cancer Prev; 2014; 15(14):5819-23. PubMed ID: 25081707
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of microvascular density for response to anlotinib in advanced NSCLC.
Liu D; Ding G
Medicine (Baltimore); 2022 Jan; 101(3):e28647. PubMed ID: 35060554
[TBL] [Abstract][Full Text] [Related]
40. [Expression of maspin and its relation to tumor vascularization in epithelian ovarian cancer].
Ma Y; Peng ZL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):223-7. PubMed ID: 19462894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
